Nebraska Medicine-Bellevue — Bellevue, Nebraska

Nebraska Medicine-Bellevue is a clinical research site located in Bellevue, Nebraska, United States 68123.

Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Nebraska Medicine-Bellevue has participated in 100 clinical trials with 87 currently active.

Therapeutic areas: Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Plasma Cell Myeloma.

Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, University of Nebraska.

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Medicine-Bellevue?

Nebraska Medicine-Bellevue has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Medicine-Bellevue conducted?

Nebraska Medicine-Bellevue has 100 clinical trials on record, with 87 currently active. Their work covers Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Plasma Cell Myeloma.

Is Nebraska Medicine-Bellevue accredited by Crixeo Health?

Nebraska Medicine-Bellevue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Medicine-Bellevue?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.